Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-14-020291
Filing Date
2014-03-17
Accepted
2014-03-17 16:28:50
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a14-2839_110k.htm 10-K 1991861
2 EX-21 a14-2839_1ex21.htm EX-21 1315
3 EX-23 a14-2839_1ex23.htm EX-23 3786
4 EX-31.1 a14-2839_1ex31d1.htm EX-31.1 10686
5 EX-31.2 a14-2839_1ex31d2.htm EX-31.2 10549
6 EX-32.1 a14-2839_1ex32d1.htm EX-32.1 5645
7 EX-32.2 a14-2839_1ex32d2.htm EX-32.2 5651
14 GRAPHIC g28391bmi001.gif GRAPHIC 16148
  Complete submission text file 0001104659-14-020291.txt   11420801

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT sgyp-20131231.xml EX-101.INS 1535022
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20131231.xsd EX-101.SCH 89211
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20131231_cal.xml EX-101.CAL 72108
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20131231_def.xml EX-101.DEF 433674
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgyp-20131231_lab.xml EX-101.LAB 1135154
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20131231_pre.xml EX-101.PRE 604159
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35268 | Film No.: 14697919
SIC: 2834 Pharmaceutical Preparations